1. Home
  2. CTRI vs CGON Comparison

CTRI vs CGON Comparison

Compare CTRI & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • CGON
  • Stock Information
  • Founded
  • CTRI 1909
  • CGON 2010
  • Country
  • CTRI United States
  • CGON United States
  • Employees
  • CTRI N/A
  • CGON N/A
  • Industry
  • CTRI
  • CGON
  • Sector
  • CTRI
  • CGON
  • Exchange
  • CTRI Nasdaq
  • CGON NYSE
  • Market Cap
  • CTRI 1.8B
  • CGON 2.0B
  • IPO Year
  • CTRI 2024
  • CGON 2024
  • Fundamental
  • Price
  • CTRI $21.21
  • CGON $26.51
  • Analyst Decision
  • CTRI Hold
  • CGON Strong Buy
  • Analyst Count
  • CTRI 6
  • CGON 10
  • Target Price
  • CTRI $19.50
  • CGON $64.44
  • AVG Volume (30 Days)
  • CTRI 1.1M
  • CGON 809.8K
  • Earning Date
  • CTRI 07-28-2025
  • CGON 08-07-2025
  • Dividend Yield
  • CTRI N/A
  • CGON N/A
  • EPS Growth
  • CTRI N/A
  • CGON N/A
  • EPS
  • CTRI 0.00
  • CGON N/A
  • Revenue
  • CTRI $2,659,287,000.00
  • CGON $662,000.00
  • Revenue This Year
  • CTRI $5.94
  • CGON N/A
  • Revenue Next Year
  • CTRI $5.40
  • CGON $25,206.93
  • P/E Ratio
  • CTRI $4,675.85
  • CGON N/A
  • Revenue Growth
  • CTRI N/A
  • CGON 224.51
  • 52 Week Low
  • CTRI $14.46
  • CGON $14.80
  • 52 Week High
  • CTRI $24.60
  • CGON $40.47
  • Technical
  • Relative Strength Index (RSI)
  • CTRI N/A
  • CGON 54.72
  • Support Level
  • CTRI N/A
  • CGON $25.80
  • Resistance Level
  • CTRI N/A
  • CGON $27.56
  • Average True Range (ATR)
  • CTRI 0.00
  • CGON 1.00
  • MACD
  • CTRI 0.00
  • CGON 0.04
  • Stochastic Oscillator
  • CTRI 0.00
  • CGON 67.97

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: